In Kevin Dyches’ mind, the future is yellow. Dyna-Tek Industries, a company Kevin and his wife, Sandra, bought five years ago, has developed synthetic urine for the research industry.

One of their first customers is the Centers for Disease Control and Prevention, which made a big purchase this summer and has hinted it could be a major buyer long into the future. Other research institutions and laboratories are also looking into Dyna-Tek’s product, called Surine.

“We have been very blessed with this,” said Dyches, who handles finances and marketing for the three-person company discreetly tucked away in a suburban Kansas City office park. “It was pretty discouraging until about a year ago.”

While the business plan might induce stifled giggles, synthetic urine is a serious matter in the laboratory industry.

Researchers, drug-testing labs and other institutions buy thousands of gallons of the real stuff, mostly to calibrate the equipment used to test regular urine samples for drugs or other substances. Researchers periodically check the accuracy of their equipment by introducing samples that have been intentionally spiked with chemicals.

More here.